Genetic testing revealed tumor mutational burden-high (TMB-H) and microsatellite instability-high (MSI-H), and immunohistochemistry (IHC) showed high programmed death-ligand 1 (PD-L1) expression. The gene discussed is CD274; the disease is neoplasm.